BPIQ Blog

Aug 19, 20221 min read

Biopharma Daily Pulse - 08/19/22

$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...

Aug 19, 20221 min read

$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...

Jun 8, 20222 min read

$XBI $73.21 | +0.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA +2.2% Moderna Announces...

Jun 8, 20222 min read

$XBI $73.21 | +0.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA +2.2% Moderna Announces...

Jun 7, 20222 min read

$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...

Jun 7, 20222 min read

$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...

Jun 30, 20214 min read

Summary: CVM reported its long-awaited Phase 3 results from its head & neck cancer trial for its immuno-therapy agent, Multikine, on June...

Our platform helps you uncover your next biotech investment opportunity